Literature DB >> 29157976

Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses.

Núria Climent1, Isabel García2, Marco Marradi2, Fabrizio Chiodo3, Laia Miralles1, María José Maleno1, José María Gatell4, Felipe García4, Soledad Penadés2, Montserrat Plana5.   

Abstract

Gold nanoparticles (GNPs) decorated with glycans ameliorate dendritic cells (DC) uptake, antigen-presentation and T-cells cross-talk, which are important aspects in vaccine design. GNPs allow for high antigen loading, DC targeting, lack of toxicity and are straightforward prepared and easy to handle. The present study aimed to assess the capacity of DC to process and present HIV-1-peptides loaded onto GNPs bearing high-mannoside-type oligosaccharides (P1@HM) to autologous T-cells from HIV-1 patients. The results showed that P1@HM increased HIV-specific CD4+ and CD8+ T-cell proliferation and induced highly functional cytokine secretion compared with HIV-peptides alone. P1@HM elicits a highly efficient secretion of pro-TH1 cytokines and chemokines, a moderate production of pro-TH2 and significant higher secretion of pro-inflammatory cytokines such as TNF-α and IL-1β. Thus, co-delivery of HIV-1 antigens and HM by GNPs is an excellent vaccine delivery system inducing HIV-specific cellular immune responses in HIV+ patients, being a promising approach to improve anti-HIV-1 vaccines.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CMV; Cellular immunity; Gold nanoparticles (GNPs); HIV-1; High-mannoside-type oligosaccharides; Vaccine

Mesh:

Substances:

Year:  2017        PMID: 29157976     DOI: 10.1016/j.nano.2017.11.009

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  15 in total

1.  Multicomponent gold nano-glycoconjugate as a highly immunogenic and protective platform against Burkholderia mallei.

Authors:  Daniel Tapia; Javier I Sanchez-Villamil; Alfredo G Torres
Journal:  NPJ Vaccines       Date:  2020-09-10       Impact factor: 7.344

Review 2.  Functionalized gold nanoparticles: promising and efficient diagnostic and therapeutic tools for HIV/AIDS.

Authors:  Shikha Gulati; Parinita Singh; Anchita Diwan; Ayush Mongia; Sanjay Kumar
Journal:  RSC Med Chem       Date:  2020-10-01

3.  Glycan-binding profile of DC-like cells.

Authors:  Eugenia M Rapoport; Ekaterina V Moiseeva; Dmitry A Aronov; Sergey V Khaidukov; Galina V Pazynina; Svetlana V Tsygankova; Ivan M Ryzhov; Ivan M Belyanchikov; Tatiana V Tyrtysh; Kenneth C McCullough; Nicolai V Bovin
Journal:  Glycoconj J       Date:  2019-12-13       Impact factor: 2.916

4.  Tumor Microenvironment Stimuli-Responsive Polymeric Prodrug Micelles for Improved Cancer Therapy.

Authors:  Zhiqiang Zhang; Miao Yu; Tong An; Jun Yang; Meijuan Zou; Yinglei Zhai; Wei Sun; Gang Cheng
Journal:  Pharm Res       Date:  2019-12-10       Impact factor: 4.200

Review 5.  Recent advances on smart glycoconjugate vaccines in infections and cancer.

Authors:  Marko Anderluh; Francesco Berti; Anna Bzducha-Wróbel; Fabrizio Chiodo; Cinzia Colombo; Federica Compostella; Katarzyna Durlik; Xhenti Ferhati; Rikard Holmdahl; Dragana Jovanovic; Wieslaw Kaca; Luigi Lay; Milena Marinovic-Cincovic; Marco Marradi; Musa Ozil; Laura Polito; Josè Juan Reina; Celso A Reis; Robert Sackstein; Alba Silipo; Urban Švajger; Ondřej Vaněk; Fumiichiro Yamamoto; Barbara Richichi; Sandra J van Vliet
Journal:  FEBS J       Date:  2021-06-01       Impact factor: 5.622

Review 6.  Myeloid C-Type Lectin Receptors in Tuberculosis and HIV Immunity: Insights Into Co-infection?

Authors:  Kubra F Naqvi; Janice J Endsley
Journal:  Front Cell Infect Microbiol       Date:  2020-06-03       Impact factor: 5.293

Review 7.  Dendritic Cells in HIV/SIV Prophylactic and Therapeutic Vaccination.

Authors:  Eun-Ju Ko; Marjorie Robert-Guroff
Journal:  Viruses       Date:  2019-12-24       Impact factor: 5.048

8.  Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed TH1-TH17 Immunity, Correlated with Increased Protection against Burkholderia pseudomallei.

Authors:  Daniel Tapia; Javier I Sanchez-Villamil; Heather L Stevenson; Alfredo G Torres
Journal:  mBio       Date:  2021-06-29       Impact factor: 7.867

Review 9.  Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases.

Authors:  Lev A Dykman
Journal:  Expert Rev Vaccines       Date:  2020-04-28       Impact factor: 5.217

Review 10.  Advancements in prophylactic and therapeutic nanovaccines.

Authors:  Prateek Bhardwaj; Eshant Bhatia; Shivam Sharma; Nadim Ahamad; Rinti Banerjee
Journal:  Acta Biomater       Date:  2020-04-05       Impact factor: 10.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.